Finance

Lists
INNO:CNSX
Innocan Pharma Corp
CAD 1,90
0,00%
(0,00) 1D
15 Okt., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for INNO...
Open
CAD 1,80
High
CAD 1,90
Low
CAD 1,60
Mkt. cap
8,97 m
Avg. vol.
1,15 k
Volume
8,65 k
52-wk high
CAD 19,15
52-wk low
CAD 1,60
EPS
-CAD 0,30
No. of employees
8
Open
CAD 1,80
High
CAD 1,90
Low
CAD 1,60
Mkt. cap
8,97 m
Avg. vol.
1,15 k
Volume
8,65 k
52-wk high
CAD 19,15
52-wk low
CAD 1,60
EPS
-CAD 0,30
No. of employees
8
News stories
From web sources and news partners
About Innocan Pharma Corp
CEO-
Employees8
Founded2017
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
6,82 m
4,99 m
6,46 m
5,25 m
Cost of goods sold
631,00 k
558,00 k
575,00 k
481,00 k
Cost of revenue
631,00 k
558,00 k
575,00 k
481,00 k
Research and development expenses
415,00 k
161,00 k
184,00 k
-9,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,99 m
5,19 m
6,49 m
5,29 m
Operating expense
7,41 m
5,35 m
6,68 m
5,28 m
Total operating expenses
8,04 m
5,91 m
7,25 m
5,76 m
Operating income
-1,22 m
-922,00 k
-786,00 k
-508,00 k
Other non operating income
-200,00 k
1,93 m
7,00 k
330,00 k
EBT including unusual items
-1,43 m
1,59 m
-822,00 k
-214,00 k
EBT excluding unusual items
-1,30 m
1,00 m
-786,00 k
-184,00 k
Income tax expense
220,00 k
-262,00 k
64,00 k
-64,00 k
Effective tax rate
-15,36%
-16,45%
-7,79%
29,91%
Other operating expenses
-
-
-
-
Net income
-1,95 m
2,00 m
-972,00 k
-34,00 k
Net profit margin
-28,54%
40,00%
-15,03%
-0,65%
Earnings per share
-
-
-
-
Interest and investment income
7,00 k
-
-
10,00 k
Interest expense
-
-3,00 k
-7,00 k
-16,00 k
Net interest expenses
7,00 k
-3,00 k
-7,00 k
-6,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,21 m
-910,00 k
-778,00 k
-503,00 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme